All In Biotech

Drug Trial Radar · NCT02662907

Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy

Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

175

Actual

Start

Feb 1, 2016

Primary completion

Feb 2, 2027

Study completion Feb 2, 2027

Sponsor

Lead sponsor
M.D. Anderson Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
IRG
First posted
Jan 26, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical research study is to learn if exercising the muscles that help you cough and swallow, called expiratory muscle strength training (EMST), can help reduce the risk of pneumonia due to aspiration (inhaling saliva instead of swallowing it) in patients who have had radiation for head and neck cancer.

Conditions

  • Head and Neck Cancer

Interventions

  • Barium SwallowProcedure

    Participants receive modified barium swallow at baseline and after 8 weeks of using the EMST device

  • QuestionnairesBehavioral

    Questionnaires completed about symptoms and quality of life at baseline, after 8 weeks of using the EMST device, and 12 months after completing the study.

  • Expiratory Muscle Strength Training (EMST) DeviceDevice

    Participant uses the EMST device at home on a 5-5-5 schedule (5 repetitions, 5 sets, 5 days per week) for 8 weeks.

  • Digital ManometerDevice

    Digital manometer used to test how forcefully participant is able to exhale and cough at baseline, and one time each week for 8 weeks while using the EMST device.

  • Neurocognitive ExamsBehavioral

    Participants given neurocognitive exams at baseline.

  • BariumDrug

    Participants receive barium prior to modified barium swallow at baseline and after 8 weeks of using the EMST device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Association Between Aspiration and Expiratory Function Using Expiratory Training in Post-Radiotherapy H&N Cancer SurvivorsTime frame: 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Texas MD Anderson Cancer Center

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.